Adenoviral Vectors for Gene Therapy
- Publisher's listprice EUR 231.00
-
97 990 Ft (93 324 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 9 799 Ft off)
- Discounted price 88 191 Ft (83 992 Ft + 5% VAT)
97 990 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 3
- Publisher Academic Press
- Date of Publication 25 April 2025
- ISBN 9780323898218
- Binding Hardback
- No. of pages906 pages
- Size 235x191 mm
- Weight 450 g
- Language English 700
Categories
Long description:
Adenoviral Vectors for Gene Therapy, Third Edition, provides detailed, comprehensive coverage of gene delivery vehicles based on the adenovirus that is emerging as an important tool in gene therapy. These exciting new therapeutic agents have great potential for the treatment of disease, as platforms for gene therapy and gene editing, as well as for oncology approaches, making them class leading agents in the gene-advanced therapies arena.
The fully updated and expanded third edition covers the basic biology of adenoviruses and highlights the potential use of adenoviral vectors for the treatment of disease, including their construction, propagation, and purification, cutting-edge vectorology, and the use of adenoviral vectors in preclinical animal models. The book also considers the regulatory issues surrounding human clinical gene therapy trials. New chapters include adenoviral vaccines for veterinary applications, adenoviruses for gene editing, nonhuman primate adenoviruses, COVID-19 vaccines, vaccine applications, and oncolytic adenoviruses for antitumor immunization. This broad scope of information provides a solid overview of the field, allowing the reader to gain a complete understanding of the development and use of adenoviral vectors.
- Provides complete coverage of the basic biology of adenoviruses, as well as their construction, propagation, and purification of adenoviral vectors
- Introduces common strategies for the development of adenoviral vectors, along with cutting-edge methods for their improvement
- Demonstrates noninvasive imaging of adenovirus-mediated gene transfer
- Discusses the utility of adenoviral vectors in animal disease models
- Considers Food and Drug Administration regulations for human clinical trials
Table of Contents:
1. Structural Biology of Adenovirus
2. Biology of Adenovirus Cell Entry: Receptors, Pathways, Mechanisms
3. Adenovirus Replication
4. Adenoviral Vector Construction I: Mammalian Systems
5. Adenoviral Vector Construction II: Bacterial Systems
6. Adenoviral Vector Packing Cell Lines
7. Purification of Adenovirus
8. Innate Immune Response to Adenovirus
9. Antibodies to Adenovirus
10. Methods to Mitigate Immune Response
11. Xenogenic Adenoviral Vectors as Vaccines
12. Adenoviral Vector Targeting
13. Helper-Dependent Adenovirus
14. Hybrid Adenoviral Vectors
15. Canine Adenovirus
16. Oncolytic Adenovirus
17. Imaging Analysis
18. Adenoviral Vaccines - Cancer
19. Adenoviral Vaccines - Infectious Disease
20. Adenoviral Vaccines - COVID 19
21. Adenoviral Vectored Veterinary Vaccines
22. Utility of Adenoviral Vectors in Animal Models - CV Disease
23. Utility of Adenoviral Vectors in Animal Models - Pulmonary Disease
24. Utility of Adenoviral Vectors in Animal Models - Genetic Disease
25. Adenoviral Vectors for Gene Editing
26. Manufacturing and Upscaling
27. Regulation of Adenoviral Vector-Based Therapies: An FDA Perspective
